Page last updated: 2024-08-23

phosphotyrosine and cyclin d1

phosphotyrosine has been researched along with cyclin d1 in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (7.14)18.2507
2000's10 (71.43)29.6817
2010's3 (21.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bertics, PJ; Frank, SJ; Houtman, JC; Jiang, J; Kim, SO; Ruppert, JM1
Ieraci, A; Maina, F; Panté, G; Ponzetto, C; Prunotto', C1
Arnold, MD; Frist, AY; Pulford, K; Seth, P; Turturro, F1
Beebe, JS; Dmitrovsky, E; Dragnev, KH; Freemantle, SJ; Knauth, EA; Lonardo, F; Ma, Y; Memoli, N; Sekula, D1
Acosta, JJ; Calcabrini, A; Dominguez-Caceres, MA; García-Martínez, JM; González, L; Lazaro-Trueba, I; Martín-Pérez, J; Muñoz, RM; Subtil-Rodríguez, A1
Fassett, J; Hansen, LK; Tobolt, D1
Bhalla, K; Jove, R; Lee, FY; List, A; Nam, S; Smith, D; Vultur, A; Williams, A1
Chen, J; Kawamata, N; Koeffler, HP1
Bernaciak, TM; Fox, EM; Shupnik, MA; Silva, CM; Weaver, AM; Wen, J1
Da Silva, T; Dumont, D; Han, K; Hong, F; Larrea, MD; Liang, J; Shao, SH; Slingerland, JM1
Basolo, F; Bellelli, R; Castellone, MD; De Falco, V; Fusco, A; Gutkind, JS; Muthu, M; Rao, DM; Santoro, M1
Brown, C; Buettner, R; Hedvat, M; Jensen, M; Jove, R; Schroeder, A; Scuto, A; Starr, R; Yang, F1
Diakonova, M; Oladimeji, P; Rider, L; Tao, J1
Budde, E; Chan, WC; Chen, RW; Kwak, LW; Mei, M; Mohanty, A; Müschen, M; Ngo, VN; Nguyen, TV; Pham, LV; Phan, A; Popplewell, L; Rosen, ST; Sandoval, N; Weisenburger, DD1

Other Studies

14 other study(ies) available for phosphotyrosine and cyclin d1

ArticleYear
Growth hormone-induced alteration in ErbB-2 phosphorylation status in 3T3-F442A fibroblasts.
    The Journal of biological chemistry, 1999, Dec-10, Volume: 274, Issue:50

    Topics: 3T3 Cells; Alkaline Phosphatase; Animals; Antibodies; Cyclin D1; Epidermal Growth Factor; ErbB Receptors; Gene Expression Regulation; Growth Inhibitors; Human Growth Hormone; Humans; Interleukin-6; Janus Kinase 2; Leukemia Inhibitory Factor; Lymphokines; Mice; Mitogen-Activated Protein Kinases; Phosphoprotein Phosphatases; Phosphorylation; Phosphotyrosine; Protein Phosphatase 2; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Receptor, ErbB-2; Recombinant Proteins

1999
Met signaling mutants as tools for developmental studies.
    The International journal of developmental biology, 2000, Volume: 44, Issue:6

    Topics: Animals; Binding Sites; Bromodeoxyuridine; Cell Differentiation; Cell Nucleus; Cells, Cultured; Consensus Sequence; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinases; DNA, Complementary; Extremities; Hepatocyte Growth Factor; Ligands; Mice; Mice, Knockout; Microscopy, Fluorescence; Models, Biological; Muscles; Mutation; Phenotype; Phosphotyrosine; Protein Binding; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-met; Signal Transduction; src Homology Domains

2000
Biochemical differences between SUDHL-1 and KARPAS 299 cells derived from t(2;5)-positive anaplastic large cell lymphoma are responsible for the different sensitivity to the antiproliferative effect of p27(Kip1).
    Oncogene, 2001, Jul-27, Volume: 20, Issue:33

    Topics: Adenoviridae; Apoptosis; Cell Cycle; Cell Cycle Proteins; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair 5; Culture Media, Serum-Free; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Genetic Vectors; Humans; Isoenzymes; Lymphoma, Large B-Cell, Diffuse; Neoplasm Proteins; Phospholipase C gamma; Phosphoproteins; Phosphoric Monoester Hydrolases; Phosphorylation; Phosphotyrosine; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Recombinant Fusion Proteins; S Phase; Transfection; Translocation, Genetic; Tumor Cells, Cultured; Tumor Suppressor Proteins; Type C Phospholipases

2001
Evidence for the epidermal growth factor receptor as a target for lung cancer prevention.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:1

    Topics: Antineoplastic Agents; Blotting, Western; Carcinogens; Cell Transformation, Neoplastic; Cyclin D1; DNA Primers; ErbB Receptors; Gene Expression Regulation; Humans; Lung Neoplasms; Mitosis; Nitrosamines; Phosphotyrosine; Reverse Transcriptase Polymerase Chain Reaction; Transfection; Tretinoin

2002
Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways.
    Molecular endocrinology (Baltimore, Md.), 2003, Volume: 17, Issue:11

    Topics: Animals; Cell Division; Cell Line, Tumor; Cyclin D1; Enzyme Activation; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphotyrosine; Prolactin; Protein-Tyrosine Kinases; Proto-Oncogene Proteins pp60(c-src); Sheep; Signal Transduction

2003
Type I collagen structure regulates cell morphology and EGF signaling in primary rat hepatocytes through cAMP-dependent protein kinase A.
    Molecular biology of the cell, 2006, Volume: 17, Issue:1

    Topics: Animals; Cell Adhesion; Cell Shape; Cells, Cultured; Collagen Type I; Cyclic AMP-Dependent Protein Kinases; Cyclin D1; DNA; Epidermal Growth Factor; ErbB Receptors; Gene Expression Regulation; Hepatocytes; Microscopy, Electron, Scanning; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphotyrosine; Protein Kinase Inhibitors; Rats; Signal Transduction

2006
Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cells.
    Molecular cancer therapeutics, 2007, Volume: 6, Issue:4

    Topics: Apoptosis; bcl-X Protein; Cell Count; Cell Survival; Cyclin D1; Dasatinib; DNA, Neoplasm; Down-Regulation; Drug Resistance, Neoplasm; HL-60 Cells; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Phosphotyrosine; Protein Binding; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Pyrimidines; Signal Transduction; src-Family Kinases; STAT5 Transcription Factor; Thiazoles

2007
Suberoylanilide hydroxamic acid (SAHA; vorinostat) suppresses translation of cyclin D1 in mantle cell lymphoma cells.
    Blood, 2007, Oct-01, Volume: 110, Issue:7

    Topics: Cell Line, Tumor; Cyclin D1; Down-Regulation; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Lymphoma, Mantle-Cell; Phosphatidylinositol 3-Kinases; Phosphotyrosine; Protein Biosynthesis; RNA, Messenger; Signal Transduction; Vorinostat

2007
Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.
    Molecular endocrinology (Baltimore, Md.), 2008, Volume: 22, Issue:8

    Topics: Breast Neoplasms; Cell Count; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Drug Resistance, Neoplasm; ErbB Receptors; Estradiol; Estrogen Receptor alpha; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Humans; Phosphorylation; Phosphotyrosine; Proto-Oncogene Proteins pp60(c-src); Signal Transduction; STAT5 Transcription Factor; Tamoxifen; Transcription, Genetic

2008
Phosphorylation of p27Kip1 regulates assembly and activation of cyclin D1-Cdk4.
    Molecular and cellular biology, 2008, Volume: 28, Issue:20

    Topics: Amino Acid Substitution; Catalysis; Cell Line, Tumor; Cyclin D1; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p27; Enzyme Activation; G1 Phase; Humans; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Phosphotyrosine; Protein Binding; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Threonine

2008
The beta-catenin axis integrates multiple signals downstream from RET/papillary thyroid carcinoma leading to cell proliferation.
    Cancer research, 2009, Mar-01, Volume: 69, Issue:5

    Topics: beta Catenin; Carcinoma, Papillary; Cell Nucleus; Cell Proliferation; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Cyclin D1; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Phosphotyrosine; Promoter Regions, Genetic; Proto-Oncogene Proteins c-ret; Signal Transduction; TCF Transcription Factors; Thyroid Neoplasms

2009
Sorafenib induces growth arrest and apoptosis of human glioblastoma cells through the dephosphorylation of signal transducers and activators of transcription 3.
    Molecular cancer therapeutics, 2010, Volume: 9, Issue:4

    Topics: Apoptosis; Benzenesulfonates; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Cyclin E; DNA, Neoplasm; Glioblastoma; Humans; Interleukin-6; Janus Kinase 1; Janus Kinase 2; Mutant Proteins; Myeloid Cell Leukemia Sequence 1 Protein; Niacinamide; Oncogene Proteins; Phenylurea Compounds; Phosphorylation; Phosphotyrosine; Protein Binding; Protein Tyrosine Phosphatases; Proto-Oncogene Proteins c-bcl-2; Pyridines; Signal Transduction; Sorafenib; src-Family Kinases; STAT3 Transcription Factor; Tumor Cells, Cultured; Vanadates

2010
PAK1-Nck regulates cyclin D1 promoter activity in response to prolactin.
    Molecular endocrinology (Baltimore, Md.), 2011, Volume: 25, Issue:9

    Topics: Adaptor Proteins, Signal Transducing; Cell Line, Tumor; Cell Nucleus; Cyclin D1; Humans; Models, Biological; Nuclear Localization Signals; Oncogene Proteins; p21-Activated Kinases; Phosphorylation; Phosphotyrosine; Prolactin; Promoter Regions, Genetic; Protein Binding; Protein Transport

2011
Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma.
    Blood, 2019, 01-24, Volume: 133, Issue:4

    Topics: Cell Line, Tumor; Cell Survival; Chromatin; Cyclin D1; Gene Expression Regulation, Neoplastic; Genetic Loci; HEK293 Cells; Histone Deacetylase 1; Histone Deacetylase 2; Histones; Humans; Interleukins; Lymphoma, Mantle-Cell; Phosphotyrosine; Protein Binding; Protein Processing, Post-Translational; SOXC Transcription Factors; STAT3 Transcription Factor; Up-Regulation

2019